Matthew L Isherwood
Matthew Isherwood completed his BSc and PhD in organic chemistry at the University of Manchester Institute of Science and Technology (UMIST), UK. He performed postdoctoral work in the area of cannabinoid research at Clemson University, USA (1998) before moving to North Carolina State University to take up a postdoctoral fellowship working on the synthesis of peptidomimetics. He joined AMRI in the USA in 2001 as a senior research scientist. In 2007, Matthew moved to AMRI-Singapore where he currently works as a project leader in medicinal chemistry.
Abstracts this author is presenting:
